Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation

Authors Mortaz, Wessman, Duncan, Gray, Badawi A

Received 4 February 2012

Accepted for publication 5 March 2012

Published 10 April 2012 Volume 2012:4 Pages 91—97

DOI https://doi.org/10.2147/CEOR.S30547

Review by Single-blind

Peer reviewer comments 2

Soroush Mortaz*, Christine Wessman*, Ross Duncan, Rachel Gray, Alaa Badawi

Office of Biotechnology Genomics and Population Health, Public Health Agency of Canada, Toronto, Ontario, Canada

*Both authors contributed equally to this work

Background: Type 2 diabetes mellitus (T2DM) is a major global health problem. An estimated 20%–50% of diabetic subjects in Canada are currently undiagnosed, and around 20%–30% have already developed complications. Screening for high blood glucose levels can identify people with prediabetic conditions and permit introduction of timely and effective prevention. This study examines the benefit of screening for impaired fasting glucose (IFG) and T2DM. If intervention is introduced at this prediabetic stage, it can be most effective in delaying the onset and complications of T2DM.
Methods: Using a Markov model simulation, we compare the cost-effectiveness of screening for prediabetes (IFG) and T2DM with the strategy of no screening. An initial cohort of normoglycemic, prediabetic, or undiagnosed diabetic adults with one or more T2DM risk factors was used to model the strategies mentioned over a 10-year period. Subjects without known prediabetes or diabetes are screened every 3 years and persons with prediabetes were tested for diabetes on an annual basis. The model weighs the increase in quality-adjusted life-years (QALYs) associated with early detection of prediabetes and earlier diagnosis of T2DM due to lifestyle intervention and early treatment in asymptomatic subjects.
Results: Costs for each QALY gained were $2281 for conventional screening compared with $2890 for no screening. Thus, in this base-case analysis, conventional screening with a frequency of once every 3 years was favored over no screening. Furthermore, conventional screening was more favorable compared with no screening over a wide range of willingness-to-pay thresholds. Changing the frequency of screening did not affect the overall results. Screening persons without diabetes or prediabetes on an annual basis had small effects on the cost-effectiveness ratios. Screening with a frequency of once every 5 years resulted in the lowest cost per QALY ($2117). Lack of screening costs the health care system $4812 more than the cost of screening once every 5 years.
Conclusion: The increased cost per QALY of not screening is due to the costs of complications caused downstream of T2DM. By ensuring that IFG screening occurs every 3 years for those without prediabetes and every year for those with prediabetes, the health and financial benefits related to T2DM are improved in Canada.

Keywords: type 2 diabetes, Markov model, economic analysis, cost-effectiveness, quality-adjusted life-years

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Toll-like receptor cascade and gene polymorphism in host–pathogen interaction in Lyme disease

Rahman S, Shering M, Ogden NH, Lindsay R, Badawi A

Journal of Inflammation Research 2016, 9:91-102

Published Date: 31 May 2016

Relationship between insulin resistance and plasma vitamin D in adults

Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:297-303

Published Date: 7 July 2014

The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults

Da Costa LA, Arora P, García-Bailo B, Karmali M, El-Sohemy A, Badawi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:347-355

Published Date: 4 October 2012

A common polymorphism near the interleukin-6 gene modifies the association between dietary fat intake and insulin sensitivity

Cuda C, Garcia-Bailo B, Karmali M, El-Sohemy A, Badawi A

Journal of Inflammation Research 2012, 5:1-6

Published Date: 9 January 2012

Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress

Bibiana Garcia-Bailo, Ahmed El-Sohemy, Pierre S Haddad, et al

Biologics: Targets and Therapy 2011, 5:7-19

Published Date: 19 January 2011

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010